JAMP Pharma Group signs a landmark partnership agreement

JAMP Pharma Group signs a landmark partnership agreement

Canadian pharmaceutical company JAMP Pharma Group has signed an exclusive agreement with global speciality biopharmaceutical company Alvotech for the Canadian commercial rights to five biosimilars. The current market value of the branded sales for these five biosimilars is estimated to be exceeding $2 billion annually in Canada.  Read the Press Release

 

2020 Member Forum

September 15, 2020
CAPDM Members: Please Log In to obtain member rate

MORE INFO

2021 Boot Camps


Dates & Locations TBD

MORE INFO

Executive Conference

January 11 - 12, 2021
Montreal Airport Marriott In-Terminal Hotel
Dorval, QC

MORE INFO

Annual Conference

May 2 - 5, 2021
JW MARRIOTT NASHVILLE
Nashville, Tennessee

MORE INFO